GC CELL CORPORATION
Cell and gene therapy specialist with integrated CDMO, bio-logistics, and cell banking.
144510 | KO
Overview
Corporate Details
- ISIN(s):
- KR7144510005
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 이현로30번길 107, 용인시
- Website:
- http://gccell.com/en/main.do
- Sector:
- Manufacturing
Description
GC CELL CORPORATION specializes in cell and gene therapy, providing a fully integrated value chain from research to commercialization. The company's core offerings include end-to-end Contract Development and Manufacturing Organization (CDMO) services for autologous and allogeneic cell therapies, comprehensive bio-logistics, and cell banking. Its integrated model supports partners throughout the entire drug life cycle, from initial development and manufacturing to clinical trials and commercial distribution. In addition to its service-based solutions, GC CELL develops proprietary cell therapy products, including Immuncell-LC, an adjuvant therapy for hepatocellular carcinoma. The company focuses on advancing treatments in areas such as immune-oncology and delivering customized solutions to enhance patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-11 00:00 |
의결권대리행사권유참고서류
|
Korean | 345.3 KB | ||
| 2022-03-07 00:00 |
[기재정정]주주총회소집결의
|
Korean | 14.0 KB | ||
| 2022-02-10 00:00 |
주주총회소집결의
|
Korean | 8.2 KB | ||
| 2022-02-10 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.5 KB | ||
| 2022-02-10 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.8 KB | ||
| 2022-01-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2022-01-05 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 56.1 KB | ||
| 2021-12-30 00:00 |
자기주식처분결과보고서
|
Korean | 15.0 KB | ||
| 2021-12-28 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 25.5 KB | ||
| 2021-12-28 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 119.0 KB | ||
| 2021-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2021-12-09 00:00 |
기타경영사항(특허권취득)(자율공시)(형질전환된 T세포를 이용한 제대혈 유래 자연살해세포의 배양방법)
|
Korean | 5.3 KB | ||
| 2021-11-15 00:00 |
분기보고서 (2021.09)
|
Korean | 2.7 MB | ||
| 2021-11-09 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.9 KB | ||
| 2021-11-09 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.9 KB |
Automate Your Workflow. Get a real-time feed of all GC CELL CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GC CELL CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GC CELL CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
